Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baird Medical Investment HoldingsBDMD -2.86%17 Buyback Yield % is 0.00 as of Jul. 26, 2026. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 349 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks worse than 286532.66% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings Buyback Yield % Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Buyback Yield %
0.00
0.00
0.00
-1.49
0.00
Baird Medical Investment Holdings Semi-Annual Data
BDMD vs TELA, NSPR, PAVM: Buyback Yield % Comparison
For the Medical Devices subindustry, Baird Medical Investment Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings (BDMD) has a Buyback Yield % of 0.00 as of Jul. 26, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Baird Medical Investment Holdings and its competitors. According to the industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 349 companies in the Medical Devices & Instruments industry.
Is Baird Medical Investment Holdings' Buyback Yield % too high?
Baird Medical Investment Holdings' current Buyback Yield % is 0.00. Based on the distribution chart, Baird Medical Investment Holdings ranks #999999 out of 349 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Buyback Yield % compare to TELA and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 349 companies for Buyback Yield %. This places Baird Medical Investment Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Buyback Yield % is 0.00 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Business Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
